{"id":1293,"date":"2018-08-27T10:26:42","date_gmt":"2018-08-27T01:26:42","guid":{"rendered":"http:\/\/urology.dept.med.gunma-u.ac.jp\/?p=1293"},"modified":"2018-08-27T11:51:29","modified_gmt":"2018-08-27T02:51:29","slug":"2015%e5%b9%b4%e3%80%80%e6%a5%ad%e7%b8%be%e3%83%bb%e8%ab%96%e6%96%87","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=1293","title":{"rendered":"2015\u5e74"},"content":{"rendered":"
\n
\u3010\u6559\u5ba4\u696d\u7e3e\u3011<\/dt>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u5c02\u9580\u533b\u8a66\u9a13\u306b\u5f79\u7acb\u3064\u524d\u7acb\u817a\u77e5\u8b58\u3000\u524d\u7acb\u817a\u764c\u30fb\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306e\u75ab\u5b66. Prostate Journal; 2(1):151-155, 2015.\t<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\u3001\u5ca1\u5185\u7814\u4e09\u3001\u702c\u5ddd\u7be4\u8a18\uff1a\u5f8c\u671f\u7814\u4fee\u533b\u304c\u304a\u3055\u3048\u3066\u304a\u304d\u305f\u3044\u6ccc\u5c3f\u5668\u75be\u60a3\u30a2\u30c8\u30e9\u30b9 \u2161\u75be\u60a3 \u524d\u7acb\u817a\u764c. \u6ccc\u5c3f\u5668\u5916\u79d1; 28(\u7279\u5225):93-110, 2015.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u6700\u65b0\u306e\u524d\u7acb\u817a\u304c\u3093\u8a3a\u7642\u306e\u3059\u3079\u3066\uff1a\u524d\u7acb\u817a\u304c\u3093\u306e\u8a3a\u65ad\uff1aPSA\u6e2c\u5b9a\u306e\u610f\u7fa9. \u81e8\u5e8a\u3068\u7814\u7a76; 92(5):546-550, 2015.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5c40\u6240\u9032\u884c\u524d\u7acb\u817a\u304c\u3093\u306b\u5bfe\u3059\u308b\u5185\u5206\u6ccc\u7642\u6cd5\u30fb\u653e\u5c04\u7dda\u7642\u6cd5\u4f75\u7528\u306e\u610f\u7fa9\u306b\u95a2\u3059\u308b\u7814\u7a76\u30b0\u30eb\u30fc\u30d7\uff1a\u5c40\u6240\u9032\u884c\u524d\u7acb\u817a\u304c\u3093\u306b\u5bfe\u3059\u308b\u5185\u5206\u6ccc\u7642\u6cd5\u30fb\u653e\u5c04\u7dda\u7642\u6cd5\u4f75\u7528\u306e\u610f\u7fa9\u306b\u95a2\u3059\u308b\u7814\u7a76\uff08\u65e7\u5c71\u4e2d\u73ed)\uff1a\u4e88\u5f8c\u89e3\u6790\u7d50\u679c. \u6ccc\u5c3f\u5668\u5916\u79d1; 28(8):1441-1442, 2015.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u65b0\u3057\u3044\u816b\u760d\u30de\u30fc\u30ab\u30fc\u306e\u81e8\u5e8a\u5fdc\u7528\u53ef\u80fd\u6027\u3068\u5c55\u671b\u2015proPSA\u306e\u6700\u65b0\u7814\u7a76\u6210\u679c\u3068\u672c\u90a6\u3067\u306e\u81e8\u5e8a\u6027\u80fd\u8a66\u9a13\u9032\u6357\u72b6\u6cc1\u2015. \u6ccc\u5c3f\u5668\u5916\u79d1; 28(8):1461-1463, 2015.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3068\u8a3a\u65ad\u30001.\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u6709\u52b9\u6027. Prostate Journal; 2(2):167-173, 2015.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u5c02\u9580\u533b\u8cc7\u683c\u8a66\u9a132014\u5e74\u5ea6\u89e3\u8aac\uff1a\u524d\u7acb\u817a\u80a5\u5927\u75c7\u95a2\u9023. Prostate Journal; 2(2):301-309, 2015.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5927\u6728\u3000\u4eae\u3001\u5bae\u4e45\u4fdd\u771f\u610f\uff1a\uff18\uff10\u6b73\u4ee5\u4e0a\u306e\u9ad8\u9f62\u8005\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u764c\u8a3a\u65ad. \u6ccc\u5c3f\u5668\u5916\u79d1; 28(11):1761-1769, 2015.<\/dd>\n
Shibata Y, Arai S and Honma S.\uff1aMethodological approach to the intracrine study and estimation of DHEA and DHEA-S using liquid chromatography-tandem mass spectrometry (LC-MS\/MS).. J Steroid Biochem Mol Biol; 145:193-199, 2015.<\/dd>\n
\u67f4\u7530\u5eb7\u535a\u3001\u6817\u539f\u8070\u592a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u5bae\u6fa4\u6176\u884c\u3001\u52a0\u85e4\u6625\u96c4\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u4e2d\u6751\u54f2\u4e5f\u3001\u9234\u6728\u548c\u6d69\uff1a\u7cbe\u7d22\u9759\u8108\u7624\u306b\u5bfe\u3059\u308b\u8853\u4e2d\u30a4\u30f3\u30c9\u30b7\u30a2\u30cb\u30f3\u30b0\u30ea\u30fc\u30f3\u86cd\u5149\u8840\u7ba1\u9020\u5f71\u4e0b\u9855\u5fae\u93e1\u4e0b\u4f4e\u4f4d\u7d50\u7d2e\u306e\u6709\u7528\u6027\uff1a\u4e88\u5099\u7684\u691c\u8a0e. \u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u96d1\u8a8c; 106(4):293-298, 2015.<\/dd>\n
Suzuki K, Ozono S, Yamaguchi A, Koike H, Matsui H, Nagata M, Takubo T, Miyashita K, Matsushima T and Akaza H.\uff1aA phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer.. Cancer Chemother Pharmacol; 75(2):373-380, 2015.<\/dd>\n
Suzuki K, Namiki M, Fujimoto T, Takabayashi N, Kudou K and Akaza H.\uff1aEfficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients:a Phase \u2162, randomized, open-label, parallel-group, comparative study in Japan.. Japanese J Clin Oncol; 45(12):1168-1174, 2015.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u677e\u4e95\u3000\u535a\u3001\u6cb3\u6751\u82f1\u5c06\u3001\u5e73\u6238\u7d14\u5b50\u3001\u6e0b\u8c37\u3000\u572d\u3001\u8c37\u5c71\u5948\u4fdd\u5b50\u3001\u6a4b\u672c\u667a\u7f8e\u3001\u91d1\u4e95\u9054\u660e\u3001\u4e2d\u91ce\u9686\u53f2\u3001\u5927\u91ce\u9054\u4e5f\uff1a\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u7642\u6cd5Multi-Disciplinary Team\u3068\u3057\u3066\u306e\u53d6\u308a\u7d44\u307f. \u764c\u3068\u5316\u5b66\u7642\u6cd5; 42(1):32-35, 2015.<\/dd>\n
\u9234\u6728\u548c\u6d69\uff1a\u53bb\u52e2\u62b5\u6297\u6027\u524d\u7acb\u817a\u764c\u306e\uff08CRPC)\u3078\u306e\u65b0\u305f\u306a\u308b\u6311\u6226\u3000\u5404\u7a2e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304b\u3089\u307f\u305fCRPC\u306e\u6cbb\u7642\u6226\u7565. \u6ccc\u5c3f\u5668\u5916\u79d1; 28(1):9-13, 2015.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u677e\u4e95\u3000\u535a\u3001\u6cb3\u6751\u82f1\u5c06\u3001\u5927\u91ce\u9054\u4e5f\uff1a\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u2015\u30db\u30eb\u30e2\u30f3\u7642\u6cd5\u306e\u5f79\u5272\u2015. \u764c\u3068\u5316\u5b66\u7642\u6cd5; 42(2):159-163, 2015.<\/dd>\n
\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u304c\u3093\u6cbb\u7642\u85ac\u3000\u30a2\u30d3\u30e9\u30c6\u30ed\u30f3\u9162\u9178\u30a8\u30b9\u30c6\u30eb. \u6ccc\u5c3f\u5668\u30b1\u30a2; 20(3):300-305, 2015.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u677e\u4e95\u3000\u535a\u3001\u5927\u7af9\u4f38\u660e\uff1a\u5bb6\u65cf\u6027\u524d\u7acb\u817a\u764c. \u65e5\u672c\u81e8\u5e8a; 73(\u5897\u520a6):481-485, 2015.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u5927\u7af9\u4f38\u660e\u3001\u677e\u4e95\u3000\u535a\uff1a\u6ccc\u5c3f\u5668\u79d1\u533b\u304c\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u907a\u4f1d\u6027\u30fb\u5bb6\u65cf\u6027\u75be\u60a3\uff1a\u6700\u8fd1\u306eTopics\u3000\u5bb6\u65cf\u6027\u524d\u7acb\u817a\u764c. \u6ccc\u5c3f\u5668\u5916\u79d1; 28(10):1631-1637, 2015.<\/dd>\n
\u9234\u6728\u548c\u6d69\uff1a\u53bb\u52e2\u62b5\u6297\u6027\u524d\u7acb\u817a\u304c\u3093 \u85ac\u7269\u6cbb\u7642UPDATE\uff08\u7de8\uff1a\u9234\u6728\u548c\u6d69); \u5148\u7aef\u533b\u5b66\u793e, 2015.<\/dd>\n
Miyazawa Y, Kato H, Arai S, Furuya Y, Sekine Y, Nomura M, Koike H, Matsui H, Shibata Y, Ito K and Suzuki K.\uff1aClinical endocrinological evaluation of the gonadal axis(testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonsit.. Basic and Clinical Andrology; 25:7, 2015.<\/dd>\n
\u3010\u8ffd\u52a0\u8ad6\u6587\u3011<\/dt>\n
Ishikawa H, Katoh H, Kaminuma T, Kawamura H, Ito K, Matsui H, Hirato J, Shimizu N, Takezawa Y, Tsuji H, Suzuki K, Ohno T and Nakano T; Group for Genitourinary Tumors at Gunma Heavy Ion Medical Center.\uff1aCarbon-ion radiotherapy for prostate cancer: analysis of morbidities and change In health-related quality of life.. Anticancer Res; 35(10):5559-5566, 2015.<\/dd>\n
\u5927\u6d25\u3000\u6643\u3001\u5bae\u5c3e\u6b66\u58eb\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u99ac\u5834\u606d\u5b50\u3001\u9752\u6728\u96c5\u5178\u3001\u6817\u539f\u8070\u592a\u3001\u5bae\u6fa4\u6176\u884c\u3001\u52a0\u85e4\u6625\u96c4\u3001\u5468\u6771\u5b5d\u6d69\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u91ce\u6751\u660c\u53f2\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u7267\u53e3\u8cb4\u54c9\u3001\u68ee\u7530\u5ee3\u6a39\u3001\u53e4\u4f5c\u3000\u671b\u3001\u677e\u672c\u548c\u4e45\u3001\u5bcc\u7530\u3000\u5149\u3001\u5c71\u672c\u3000\u5de7\u3001\u6797\u3000\u96c5\u9053\uff1a\u7dcf\u6392\u6cc4\u8154\u5916\u53cd\u75c7\u306b\u6709\u68d8\u7d30\u80de\u764c\u3092\u5408\u4f75\u3057\u305f\u4e00\u4f8b. \u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u96d1\u8a8c; 106(4):274-279, 2015.<\/dd>\n
Okihara K, Ochiai A, Kamoi K, Fujizuka Y, Miki T and Ito K.\uff1aComprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countries.. Int J Urol; 22(4):334-341, 2015.<\/dd>\n
\u718a\u5742\u6587\u6210\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u6751\u4e95\u3000\u52dd\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u5c71\u672c\u3000\u5de7\u3001\u8d64\u5009\u529f\u4e00\u90ce\uff1a\u4eba\u9593\u30c9\u30c3\u30af\u65bd\u8a2d\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30a2\u30f3\u30b1\u30fc\u30c8\u96c6\u8a08\u5831\u544a\uff08\u7b2c\uff19\u56de\u8abf\u67fb\uff09\u2015\u5e73\u621025\u5e74\u5ea6\u2015. \u6ccc\u5c3f\u5668\u5916\u79d1; 28(8):1451-1455, 2015.<\/dd>\n
\u718a\u5742\u6587\u6210\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u5927\u6728\u3000\u4eae\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3068\u8a3a\u65ad\u3000\u4eba\u9593\u30c9\u30c3\u30af\u306b\u304a\u3051\u308bPSA\u691c\u67fb\u306e\u73fe\u72b6\u3068PSA\u57fa\u790e\u5024\u306e\u91cd\u8981\u6027. Prostate Journal; 2(2):181-188, 2015.<\/dd>\n
Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ, de Wit R; ELM-PC 4 investigators\uff1aOrteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC4):a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.. Lancet Oncol; 16(3):338-348, 2015.<\/dd>\n
Saito S, Ito K, Yorozu A, Aoki M, Koga H, Satoh T, Ohashi T, Shigematsu N, Maruo S, Kikuchi T, Kojima S, Dokiya T, Fukushima M and Yamanaka H.\uff1aNationwide Japanese prostate cancer outcome study of permanent Iodine-125 seed implantation (J-POPS).. Int J Clin Oncol; 20(2):375-385, 2015.<\/dd>\n
\u7530\u4e2d\u5553\u5e79\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5927\u6728\u3000\u4eae\u3001\u5c71\u4e2d\u82f1\u58fd\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u7814\u7a76\u73ed(\u7530\u4e2d\u73ed)\u5e73\u621022\u5e74\u5ea6\u7d50\u679c\u5831\u544a. \u6ccc\u5c3f\u5668\u5916\u79d1; 28(8):1447-1450, 2015.<\/dd>\n
Nozawa M, Mukai H, Takahashi S, Uemura H, Kosaka T, Onozawa Y, Miyazaki J, Suzuki K, Okihara K, Arai Y, Komba T, Kato M, Nakai Y, Furuse H, Kume H, Ide H, Kitamura H, Yokomizo A, Kimura T, Tomita Y, Ohno K and Kakehi Y.\uff1aJapanese phase \u2160study of cabazitaxel in metastatic castration-resistant prostate cancer.. Int J Clin Oncol; 20(5):1026-1034, 2015.<\/dd>\n
\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a\u691c\u67fb\u3068\u81e8\u5e8a\u306e\u30b3\u30e9\u30dc\u3067\u7406\u89e3\u3059\u308b\u816b\u760d\u30de\u30fc\u30ab\u30fc\uff1aPSA\u81e8\u5e8a\u7de8. \u81e8\u5e8a\u691c\u67fb; 59:(7)656-662, 2015.<\/dd>\n
\u3010\u305d\u306e\u4ed6\u3011<\/dt>\n
\u5927\u6fa4\u82f1\u53f2\u3001\u6751\u677e\u548c\u9053\u3001\u84ee\u898b\u3000\u52dd\u3001\u6e05\u6c34\u4fe1\u660e\uff1a\u7cbe\u5de3\u5927\u7d30\u80de\u6027\u77f3\u7070\u5316\u30bb\u30eb\u30c8\u30ea\u7d30\u80de\u816b\u306e1\u4f8b. \u6ccc\u5c3f\u5668\u5916\u79d1; 29(1):83-86, 2016.<\/dd>\n
\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u77f3\u4e95\u79c0\u548c\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u72e9\u91ce\u3000\u81e8\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u5f8c\u671f\u9ad8\u9f62\u8005\u306e\u524d\u7acb\u817a\u304c\u3093\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u91cd\u8981\u6027. \u4eba\u9593\u30c9\u30c3\u30af; 30(3):570-573, 2015.<\/dd>\n
\u9ed2\u6fa4\u3000\u529f\u3001\u898b\u7530\u3000\u5c0a\uff1aMRI \u65b0\u3057\u3044\u6d3b\u7528\u306e\u6f6e\u6d41\u3068\u305d\u306e\u5b9f\u529b\u3000MRI\u304c\u62d3\u304f\u81e8\u5e8a\u3078\u306e\u65b0\u6307\u6a19\u4e88\u9632\u533b\u7642\u306b\u304a\u3051\u308bMRI\u306e\u6709\u7528\u6027\u3000\u3055\u307e\u3056\u307e\u306aMRI\u30c9\u30c3\u30af\u30b3\u30fc\u30b9\u304b\u3089\u306e\u691c\u8a3c. \u65b0\u533b\u7642; 42(6):48-51, 2015.<\/dd>\n
\u5bcc\u7530\u3000\u5149\u3001\u5c71\u672c\u3000\u5de7\u3001\u677e\u672c\u548c\u4e45\u3001\u6797\u3000\u96c5\u9053\u3001\u9577\u8c37\u5ddd\u662d\u3001\u53e4\u4f5c\u3000\u671b\uff1a\u7dad\u6301\u900f\u6790\u4e2d\u306b\u9f72\u6b6f\u3092\u5951\u6a5f\u306b\u3057\u3066\u767a\u75c7\u3057\u305fSeptic Pulmonary Embolism\u306e1\u4f8b. \u7fa4\u99ac\u533b\u5b66; 102:167-172, 2015.<\/dd>\n
\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u72e9\u91ce\u3000\u81e8\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u9ed2\u6fa4\u3000\u529f\uff1a80\u6b73\u4ee5\u4e0a\u306e\u9ad8\u9f62\u524d\u7acb\u817a\u80a5\u5927\u75c7\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u30c7\u30e5\u30bf\u30b9\u30c6\u30ea\u30c9\u306e\u52b9\u679c\u2015\u6295\u4e0e\u75c7\u4f8b\u306e\u80cc\u666f\u306b\u7740\u76ee\u3057\u305f\u691c\u8a0e\u2015. \u7fa4\u99ac\u533b\u5b66; 102:155-158, 2015.<\/dd>\n
\u66f2\u3000\u53cb\u5f18\uff1a\u5317\u95a2\u6771\u30a8\u30ea\u30a2\u3000BPH\/LUTS\u5ea7\u8ac7\u4f1a\u3000\u518a\u5b50, 2015.<\/dd>\n
\u4e95\u6238\u8c37\u6075\u3001\u6238\u585a\u771f\u5f13\u3001\u5009\u7530\u3000\u552f\u3001\u53e4\u6fa4\u88d5\u7f8e\u3001\u6238\u585a\u771f\u8863\u3001\u795e\u4fdd\u670b\u7f8e\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u5f53\u30bb\u30f3\u30bf\u30fc\u306e\u7279\u5b9a\u4fdd\u5065\u6307\u5c0e\u306e\u52b9\u679c\u3068\u8ab2\u984c. \u7fa4\u99ac\u533b\u5b66; 102:181-182, 2015.<\/dd>\n
\u795e\u4fdd\u670b\u7f8e\u3001\u6238\u585a\u771f\u8863\u3001\u53e4\u6fa4\u88d5\u7f8e\u3001\u5009\u7530\u3000\u552f\u3001\u4e95\u6238\u8c37\u6075\u3001\u6238\u585a\u771f\u5f13\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u5229\u7528\u8005\u306e\u671b\u3080\u7279\u5b9a\u4fdd\u5065\u6307\u5c0e\u306e\u691c\u8a0e\u2015\u4fdd\u5065\u6307\u5c0e\u306e\u6e80\u8db3\u5ea6\u306b\u3064\u3044\u3066\u2015. \u7fa4\u99ac\u533b\u5b66; 102:75-78, 2015.<\/dd>\n
\u95a2\u6839\u306e\u305e\u307f\u3001\u661f\u91ce\u8cb4\u7f8e\u6c5f\u3001\u591a\u80e1\u76f4\u4e5f\u3001\u9ed2\u7530\u6b63\u5df3\u3001\u690d\u7530\u660c\u7537\u3001\u5927\u7af9\u798f\u5bff\u3001\u66f2\u3000\u53cb\u5f18\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u30aa\u30f3\u30e9\u30a4\u30f3HDF\u5c0e\u5165\u306b\u3064\u3044\u3066. \u7fa4\u99ac\u533b\u5b66; 102:113-115, 2015.<\/dd>\n
\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u5009\u7530\u3000\u552f\u3001\u4e95\u6238\u8c37\u6075\u3001\u6238\u585a\u771f\u8863\u3001\u53e4\u6fa4\u88d5\u7f8e\u3001\u795e\u4fdd\u670b\u7f8e\u3001\u6817\u539f\u7167\u660c\u3001\u85e4\u4e95\u5b5d\u5c1a\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u4e73\u304c\u3093\u5bb6\u65cf\u6b74\u3092\u6709\u3059\u308b\u5973\u6027\u306e\u4e73\u304c\u3093\u306b\u5bfe\u3059\u308b\u610f\u8b58\u8abf\u67fb. \u7fa4\u99ac\u533b\u5b66; 102:187-191, 2015.<\/dd>\n
\u6a2a\u5c71\u3000\u52c7\u3001\u50b3\u7530\u548c\u6075\u3001\u9ad8\u6a4b\u96c4\u4e00\u3001\u9f4b\u85e4\u5fd7\u4e43\u3001\u95a2\u3000\u96c5\u5f66\u3001\u798f\u539f\u7f8e\u7a42\u3001\u9ad8\u6a4b\u7406\u6075\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u5fc3\u62cd\u6570\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u306b\u3088\u308b\u8840\u6db2\u691c\u67fb\u30c7\u30fc\u30bf\u306e\u5909\u5316\u306b\u3064\u3044\u3066\u306e\u75c7\u4f8b\u5831\u544a. \u7fa4\u99ac\u533b\u5b66; 102:69-74, 2015.<\/dd>\n<\/dl>\n","protected":false},"excerpt":{"rendered":"

\u3010\u6559\u5ba4\u696d\u7e3e\u3011 \u4f0a\u85e4\u4e00\u4eba\uff1a\u5c02\u9580\u533b\u8a66\u9a13\u306b\u5f79\u7acb\u3064\u524d\u7acb\u817a\u77e5\u8b58\u3000\u524d\u7acb\u817a\u764c\u30fb\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306e\u75ab\u5b66. Prostate Journal; 2(1):151-155, 2015. \u4f0a\u85e4\u4e00\u4eba\u3001\u5ca1\u5185\u7814\u4e09\u3001\u702c\u5ddd\u7be4\u8a18\uff1a\u5f8c\u671f\u7814\u4fee\u533b\u304c\u304a\u3055\u3048\u3066\u304a\u304d\u305f\u3044 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1293","post","type-post","status-publish","format-standard","hentry","category-achievements"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/1293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1293"}],"version-history":[{"count":4,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/1293\/revisions"}],"predecessor-version":[{"id":1316,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/1293\/revisions\/1316"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}